LAKEWOOD, Colo.--(BUSINESS WIRE)--Renal Ventures Management (RVM), a leading provider of dialysis services for patients suffering from chronic kidney disease, continues its efforts to raise the standard of renal patient care during National Kidney Awareness Month. George R. Aronoff, M.D., M.S., F.A.C.P., Chief Medical Officer of Renal Ventures Management, said the company is continuing its focus on practical strategies and innovative programs to achieve continued and measureable care improvements.
“We’re operating in a challenging and dynamic environment of health care reform with a stronger focus than ever on achieving quality care and improved outcomes resulting in better coverage and reimbursement,” said Aronoff, who is speaking on several renal care topics in the coming months. “We’re meeting this challenge by rewriting the standards of care for renal patients through hands-on patient care, supporting clinical research and through our industry-leading programs.”
As CMO, Dr. Aronoff directs the RV Quality programs, including RV CARE, RV Kidney Care and RV TLC. According to the United States Renal Data System 2014 Annual Data Report and internal RVM data, these programs have successfully lowered hospitalization rates due to access infections and cardiovascular events for RVM patients to just 24 percent―less than half the national average. Additionally, the programs have helped lower the all-cause first-year mortality rate at RVM centers to just 2 percent compared with the national average of 35 percent. RVM is also the most successful national dialysis provider at transitioning patients from a temporary catheter to a permanent access port, which results in fewer hospitalizations, lower mortality rates and better quality of life.
In addition to his 30 years of experience in designing and performing clinical research in hemodialysis, peritoneal dialysis, transplant and CKD patients, Dr. Aronoff maintained an active clinical practice in chronic kidney disease, dialysis and transplantation. He is also a frequent lecturer on renal care innovation, quality standards and cost-effective delivery of services.
On Friday, March 20, 2015, Dr. Aronoff discusses the critical role of the medical director in the dialysis facility in “Practical Strategies for Medical Directors to Satisfy the Conditions for Coverage.” The talk is being delivered at the Renal Physicians Association annual meeting in Baltimore, Md.
On June 24, 2015, Dr. Aronoff presents “How Dialysis Really Gets Paid For,” focusing on the administrative, financial and regulatory issues of payment to Nephrologists and dialysis units for dialysis care. The presentation is being delivered during the American Society for Artificial Internal Organs annual meeting at the society’s Practical Outpatient Dialysis Short Course, designed to provide trainees and recent graduates in Nephrology with practical guidance to managing the real-world situations that arise in outpatient dialysis practice.
Earlier this year, Dr. Aronoff presented “Salt: Is It Really a Four Letter Word?” at the NKF of Florida Renal Professional Forum in February, discussing the impact of dietary sodium intake on patients with kidney disease. The program is designed specifically for renal social workers, dietitians, nurses and technicians.
From its groundbreaking educational programs to the continued research and development of advance treatment protocols for peritoneal dialysis patients, RVM continues to influence and re-shape the renal disease industry. RVM now operates 36 centers nationwide, with 20 of those centers providing peritoneal dialysis.
About Renal Ventures Management, LLC
Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which center around collaboration, quality and effectiveness. Headquartered in Lakewood, Colo., the company operates 35 dialysis partnerships and 25 inpatient service contracts in six states. They also operate seven infusion centers in two states treating patients with various autoimmune disorders and a vascular access center in Lafayette, Louisiana. For more information, visit www.renalventures.com.
